These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7471860)

  • 61. Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia.
    Torvik K; Narverud I; Ottestad I; Svilaas A; Gran JM; Retterstøl K; Ellingvåg A; Strøm E; Ose L; Veierød MB; Holven KB
    Atherosclerosis; 2016 Sep; 252():21-27. PubMed ID: 27494447
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography.
    Nash DT; Gensini G; Esente P
    Int J Cardiol; 1982; 2(1):43-55. PubMed ID: 7129689
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cholesterol-free diet and the physiologic hyperlipidemia of pregnancy in familial hypercholesterolemia.
    Glueck CJ; Christopher C; Tsang RC; Mellies MJ
    Metabolism; 1980 Oct; 29(10):949-55. PubMed ID: 7421585
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Changes in plasma lipid and lipoprotein fractions after alteration in dietary cholesterol, polyunsaturated, saturated, and total fat in free-living normal and hypercholesterolemic children.
    Stein EA; Shapero J; McNerney C; Glueck CJ; Tracy T; Gartside P
    Am J Clin Nutr; 1982 Jun; 35(6):1375-90. PubMed ID: 7081119
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low dose colestipol in adolescents with familial hypercholesterolaemia.
    Tonstad S; Sivertsen M; Aksnes L; Ose L
    Arch Dis Child; 1996 Feb; 74(2):157-60. PubMed ID: 8660081
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality.
    Dorr AE; Gundersen K; Schneider JC; Spencer TW; Martin WB
    J Chronic Dis; 1978 Jan; 31(1):5-14. PubMed ID: 346598
    [No Abstract]   [Full Text] [Related]  

  • 67. Weight loss improves lipoprotein lipid profiles in patients with hypercholesterolemia.
    Davis TA; Anderson EC; Ginsburg AV; Goldberg AP
    J Lab Clin Med; 1985 Oct; 106(4):447-54. PubMed ID: 4045301
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE
    Artery; 1990; 17(5):281-8. PubMed ID: 2396902
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of encapsulated, low-dose colestipol in patients with hyperlipidemia.
    Linet OI; Grzegorczyk CR; Demke DM
    J Clin Pharmacol; 1988 Sep; 28(9):804-6. PubMed ID: 3230147
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of common lipoprotein disorders.
    Brown WV; Goldberg IJ; Ginsberg HN
    Prog Cardiovasc Dis; 1984; 27(1):1-20. PubMed ID: 6330792
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cholesterol, colestipol and coronary heart disease.
    Stone NJ
    J Chronic Dis; 1978 Jan; 31(1):1-3. PubMed ID: 346595
    [No Abstract]   [Full Text] [Related]  

  • 72. Combined drug therapy for familial hypercholesterolemia.
    Packard CJ; Stewart JM; Morgan HG; Lorimer AR; Shepherd J
    Artery; 1980; 7(4):281-9. PubMed ID: 7213018
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Long-term therapy of familial hypercholesterolemia in young patients with colestipol: availability of minerals and vitamins].
    Schlierf G; Vogel G; Kohlmeier M; Vuilleumier JP; Hüppe R; Schmidt-Gayk H
    Klin Wochenschr; 1985 Sep; 63(17):802-6. PubMed ID: 3932748
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dietary determinants of plasma cholesterol change in the recruitment phase of the Lipid Research Clinics Coronary Primary Prevention Trial.
    Gordon DJ; Salz KM; Roggenkamp KJ; Franklin FA
    Arteriosclerosis; 1982; 2(6):537-48. PubMed ID: 7181738
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.
    Kane JP; Malloy MJ; Ports TA; Phillips NR; Diehl JC; Havel RJ
    JAMA; 1990 Dec; 264(23):3007-12. PubMed ID: 2243428
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hyperlipoproteinemia in angiographically documented coronary artery disease.
    Eisenberg S; Tzivoni D; Stern S
    Eur J Cardiol; 1976 Dec; 4(4):469-73. PubMed ID: 187428
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of hypercholesterolemia. Can it retard atherogenesis?
    Untereker WJ
    Int J Cardiol; 1982; 2(1):57-9. PubMed ID: 7129690
    [No Abstract]   [Full Text] [Related]  

  • 78. Dietary management of patients with familial hypercholesterolaemia treated with simvastatin.
    Chisholm A; Mann J; Sutherland W; Williams S; Ball M
    Q J Med; 1992; 85(307-308):825-31. PubMed ID: 1484945
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Colestipol at varying dosage intervals in the treatment of moderate hypercholesterolaemia.
    Lyons D; Webster J; Fowler G; Petrie JC
    Br J Clin Pharmacol; 1994 Jan; 37(1):59-62. PubMed ID: 8148218
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bile acid sequestrants.
    Ast M; Frishman WH
    J Clin Pharmacol; 1990 Feb; 30(2):99-106. PubMed ID: 2179278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.